Kleijn, A., van den Bossche, W., Haefner, E., Belcaid, Z., Kloezeman, J., Dirven, C., & Lamfers, M. (2014). IT-16 COMBINATION TREATMENT WITH DELTA24-RGD AND TEMOZOLOMIDE IMPROVES SURVIVAL AND AFFECTS INTRATUMORAL IMMUNE CELL SUBSETS IN A MURINE MALIGNANT GLIOMA MODEL. Oxford University Press.

Kleijn, Anne, Wouter van den Bossche, Eric Haefner, Zineb Belcaid, Jenneke Kloezeman, Clemens Dirven, and Martine Lamfers. IT-16 COMBINATION TREATMENT WITH DELTA24-RGD AND TEMOZOLOMIDE IMPROVES SURVIVAL AND AFFECTS INTRATUMORAL IMMUNE CELL SUBSETS IN A MURINE MALIGNANT GLIOMA MODEL. Oxford University Press, 2014.

Kleijn, Anne, et al. IT-16 COMBINATION TREATMENT WITH DELTA24-RGD AND TEMOZOLOMIDE IMPROVES SURVIVAL AND AFFECTS INTRATUMORAL IMMUNE CELL SUBSETS IN A MURINE MALIGNANT GLIOMA MODEL. Oxford University Press, 2014.